| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.3 | 1e-17 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.27 | 7e-17 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |